SEC Form 4 · accession 0001645627-18-000031
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 30, 2017
Accepted (ET)
Jun 7, 2018 · 3:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 30, 2018 | P | 1,000 | $0.0378 | A | 25,131,089 | D | |
| Common Stock | May 30, 2018 | P | 1,000 | $0.0369 | A | 25,132,089 | D | |
| Common Stock | May 30, 2018 | P | 100 | $0.0369 | A | 25,132,189 | D | |
| Common Stock | May 30, 2018 | P | 1,000 | $0.037 | A | 25,133,189 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.0378 | A | 25,134,189 | D | |
| Common Stock | May 31, 2018 | P | 100 | $0.0378 | A | 25,134,289 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.037 | A | 25,135,289 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.037 | A | 25,136,289 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.037 | A | 25,137,289 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.0421 | A | 25,138,289 | D | |
| Common Stock | May 31, 2018 | P | 1,000 | $0.0417 | A | 25,139,289 | D | |
| Common Stock | Jun 1, 2018 | P | 1,000 | $0.0398 | A | 25,140,289 | D | |
| Common Stock | Jun 1, 2018 | P | 1,000 | $0.0398 | A | 25,141,289 | D | |
| Common Stock | Jun 1, 2018 | P | 1,000 | $0.0397 | A | 25,142,289 | D | |
| Common Stock | Jun 4, 2018 | P | 1,000 | $0.0378 | A | 25,143,289 | D |
Table II — derivative securities
No Table II lines on this filing.